Zelmic AB is a Swedish CRO/CDMO based in Lund — one of Europe's leading life science hubs — dedicated to topical and transdermal drug formulation. Since 2002, Zelmic has supported pharmaceutical and biotech companies from early feasibility through GMP-compliant manufacturing, combining in-house R&D with regulatory-ready infrastructure certified by the Swedish Medical Products Agency (EU-GMP, ICH Q10). Zelmic's services span product development, IMP GMP manufacturing of non-sterile medicinal products, GMP-compliant analytical chemistry, and in vitro performance testing (IVRT/IVPT), alongside formulation support, stability testing, and method development and validation. Now part of the CTR Group, Zelmic continues to help pharmaceutical and biotech sponsors move drug product candidates seamlessly from early idea to GMP-ready manufacture for first-in-human clinical trials.